Palmirotta et al. [32] reported plasma PAI-1 levels in breast cancer patients were approximately two fold higher than those observed in control subjects and were strongly dependent on cancer size, suggesting that cancer-related factors might be responsible for PAI-1 up-regulation. Here, SERPINE1 is linked to breast cancer.